# Laborie Medical Technologies to acquire Cogentix Medical for $239M

Laborie Medical Technologies will acquire Cogentix Medical for $3.85 per share in cash, totaling approximately $239 million. The transaction is expected to close in the second quarter of 2018.

- Type: Acquisition
- Announced: 2018-03-12
- Where: United States
- Value: $239.0M
- Status: announced
- Products: urology and gynecology medical devices, neuromodulation systems, cystoscopy systems, injectable bulking agents
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Laborie Medical Technologies](https://endata.com/companies/30706.md) (acquirer)
- [Cogentix Medical](https://endata.com/companies/30707.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/cogentix-medical-enters-definitive-merger-agreement-to-be-acquired-by-laborie-medical-technologies-for-a-purchase-price-of-385-per-share-in-cash-300612143.html), 2018-03-12: "This transaction helps us achieve our vision of creating value for our investors, patients and physicians in the urology and gynecology markets."
- [prnewswire.com](https://www.prnewswire.com/news-releases/laborie-medical-technologies-to-acquire-cogentix-medical-inc-for-214-million-300612023.html), 2018-03-12: "The acquisition of Cogentix advances our strategy to invest in leading technologies that provide product and channel scale to LABORIE'S existing Urology Strategic Business Unit diagnostic and therapeutic portfolio."
- [newswire.ca](https://www.newswire.ca/news-releases/laborie-medical-technologies-to-acquire-cogentix-medical-inc-for-214-million-676538113.html), 2018-03-12: "The acquisition of Cogentix advances our strategy to invest in leading technologies that provide product and channel scale to LABORIE'S existing Urology Strategic Business Unit."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.